Frankfurt - Delayed Quote • EUR Karyopharm Therapeutics Inc. (25K.F) Follow Compare 0.6294 -0.0008 (-0.13%) At close: January 30 at 4:04:15 PM GMT+1 Comparisons Indicators Technicals Corporate Events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Verex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 25K.F 1D 5D -0.51% 1M 9.77% 3M -21.83% 6M -29.33% YTD -14.25% 1Y -20.27% 5Y -95.83% All -97.94% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Recent News: 25K.F View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Verve Therapeutics (VERV) Moves 18.7% Higher: Will This Strength Last? Karyopharm Announces Preliminary Unaudited 2024 Revenue and 2025 Objectives Why Karyopharm Therapeutics (KPTI) Is Among the Best Penny Stocks to Invest In According to Media? Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Karyopharm Announces the Appointment of Lori Macomber as Chief Financial Officer Karyopharm Announces the Appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications Karyopharm Therapeutics Provides Endometrial Cancer Program Update Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare Conference Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer Karyopharm to Present Selinexor Data at the 66th American Society of Hematology Annual Meeting and Exposition Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?